Authors:
Freund, F
Boulme, F
Michel, J
Ventura, M
Moreau, S
Litvak, S
Citation: F. Freund et al., Inhibition of HIV-1 replication in vitro and in human infected cells by modified antisense oligonucleotides targeting the tRNA(Lys3) /RNA initiation complex, ANTISENSE N, 11(5), 2001, pp. 301-315
Authors:
Pradet-Balade, B
Boulme, F
Mullner, EW
Garcia-Sanz, JA
Citation: B. Pradet-balade et al., Reliability of mRNA profiling: Verification for samples with different complexities, BIOTECHNIQU, 30(6), 2001, pp. 1352-1357
Authors:
Freund, F
Boulme, F
Litvak, S
Tarrago-Litvak, L
Citation: F. Freund et al., Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex, NUCL ACID R, 29(13), 2001, pp. 2757-2765
Authors:
Boulme, F
Freund, F
Gryaznov, S
Nielsen, PE
Tarrago-Litvak, L
Litvak, S
Citation: F. Boulme et al., Study of HIV-2 primer-template initiation complex using antisense oligonucleotides, EUR J BIOCH, 267(9), 2000, pp. 2803-2811
Authors:
Mestre, B
Arzumanov, A
Singh, M
Boulme, F
Litvak, S
Gait, MJ
Citation: B. Mestre et al., Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA, BBA-GENE ST, 1445(1), 1999, pp. 86-98
Authors:
Boulme, F
Freund, F
Moreau, S
Nielsen, PE
Gryaznov, S
Toulme, JJ
Litvak, S
Citation: F. Boulme et al., Modified (PNA, 2 '-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription, NUCL ACID R, 26(23), 1998, pp. 5492-5500